Patent Issued on First Genetic Banking System
By Biotechdaily staff writers
Posted on 12 Feb 2004
The first U.S. patent to be issued for an e-genetic banking system and supporting technology has been announced.Posted on 12 Feb 2004
The system enables genetic profile data to be securely stored while remaining accessible for authorized purposes, reconsent, and reuse. The patent covers the methods, processes, and e-systems for securely storing, analyzing, and managing genetic data for translational genomic research, pharmacogenomics, and molecular diagnostics. The system, called enTrust, was developed by First Genetic Trust, Inc. (Chicago, IL, USA).
The enTrust genetic banking platform provides coordinated management of sample and phenotype data with capabilities for sample tracking and reuse, data acquisition and management, data security, and management of informed consent in support of pharmaceutical research, clinical development, as well as genetic programs in the provider and government sectors.
"We have created a novel e-technology which, for the first time, fully addresses the critical issues of genetic data privacy, confidentiality, and reuse at the information systems level,” said Arthur L. Holden, chairman and CEO of First Genetic Trust.
Related Links:
First Genetic Trust
.jpg)
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Immunofluorescence Analyzer
IFA System
New
POC Immunoassay Analyzer
Procise DX
